Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14

1.

An automated image-based method for rapid analysis of Chlamydia infection as a tool for screening antichlamydial agents.

Osaka I, Hills JM, Kieweg SL, Shinogle HE, Moore DS, Hefty PS.

Antimicrob Agents Chemother. 2012 Aug;56(8):4184-8. doi: 10.1128/AAC.00427-12. Epub 2012 May 21.

2.

Antibiotics, peptidoglycan synthesis and genomics: the chlamydial anomaly revisited.

Chopra I, Storey C, Falla TJ, Pearce JH.

Microbiology. 1998 Oct;144 ( Pt 10):2673-8. Review. No abstract available.

PMID:
9802008
3.

Use of quinolones in chlamydial infection.

Oriel JD.

Rev Infect Dis. 1989 Jul-Aug;11 Suppl 5:S1273-6. Review.

PMID:
2672254
4.

Strategic targeting of essential host-pathogen interactions in chlamydial disease.

Coombes BK, Johnson DL, Mahony JB.

Curr Drug Targets Infect Disord. 2002 Sep;2(3):201-16. Review.

PMID:
12462125
5.

How, and how efficiently, can we treat Chlamydia trachomatis infections in women?

Guaschino S, Ricci G.

Best Pract Res Clin Obstet Gynaecol. 2002 Dec;16(6):875-88. Review.

PMID:
12473288
6.

Chlamydia vaccines: strategies and status.

Igietseme JU, Black CM, Caldwell HD.

BioDrugs. 2002;16(1):19-35. Review.

PMID:
11908999
7.

Potential for antimicrobial resistance in Chlamydia pneumoniae.

Stamm WE.

J Infect Dis. 2000 Jun;181 Suppl 3:S456-9. Review.

PMID:
10839739
8.

Antibiotics effects in a rabbit model of Chlamydia pneumoniae-induced atherosclerosis.

Fong IW.

J Infect Dis. 2000 Jun;181 Suppl 3:S514-8. Review.

PMID:
10839750
9.

[Chlamydia pneumoniae].

PĂ©rez Trallero E, Montes M.

Enferm Infecc Microbiol Clin. 1991 May;9(5):292-6. Review. Spanish. No abstract available.

PMID:
1954266
10.

Evaluation of antimicrobial resistance and treatment failures for Chlamydia trachomatis: a meeting report.

Wang SA, Papp JR, Stamm WE, Peeling RW, Martin DH, Holmes KK.

J Infect Dis. 2005 Mar 15;191(6):917-23. Epub 2005 Feb 11. Review.

PMID:
15717267
11.

Effect of clinically relevant culture conditions on antimicrobial susceptibility of Chlamydia trachomatis.

Wyrick PB, Davis CH, Raulston JE, Knight ST, Choong J.

Clin Infect Dis. 1994 Nov;19(5):931-6. Review.

PMID:
7893882
12.

Target cell limitation constrains chlamydial load in persistent infections: results from mathematical modelling applied to mouse genital tract infection data.

Craig AP, Rank RG, Bowlin AK, Wand H, Wilson DP.

Pathog Dis. 2015 Feb;73(1):1-8. doi: 10.1111/2049-632X.12203. Epub 2015 Jan 30. Review.

PMID:
25044245
13.

Chlamydial infections.

Fraiz J, Jones RB.

Annu Rev Med. 1988;39:357-70. Review.

PMID:
3285782
14.

Lead Discovery Strategies for Identification of Chlamydia pneumoniae Inhibitors.

Hanski L, Vuorela P.

Microorganisms. 2016 Nov 28;4(4). pii: E43. Review.

Supplemental Content

Support Center